Hancock said in a statement "We have formally asked the Medicines Regulatory Authority to evaluate a vaccine Oxford / AstraZeneca To understand the data and determine whether it meets stringent safety standards".
و .ضاف "This letter is an important step towards launching a vaccine as quickly as possible, safely".
The UK Medicines and Healthcare Products Regulatory Agency is already evaluating the vaccine at "A renewed review" With data on safety and efficacy.
Hancock also asked the agency to approve a company vaccine Pfizer-Biontec After it has been proven effective by 95%.
Oxford and AstraZeneca published provisional results of efficacy on Monday, which showed that the vaccine can be 90% effective when given as a half dose followed by a full dose.
Britain’s chief science adviser said on Thursday that the provisional results showed the success of the Oxford / AstraZeneca vaccine.
“>
Expected AstraZeneca Four million doses will be available in Britain by the end of next month and Health Secretary Matt Hancock aims to start rolling it out before Christmas.
“We have formally requested the Medicines Regulatory Authority to evaluate a vaccine,” Hancock said in a statement Oxford / AstraZeneca To understand the data and determine whether it meets stringent safety standards.
“This message is an important step towards launching a vaccine as quickly as possible safely,” he added.
The UK Medicines and Healthcare Products Regulatory Agency is already evaluating the vaccine in a “rolling review”, with data on safety and efficacy coming in.
Hancock also asked the agency to approve a company vaccine Pfizer-Biontec After it has been proven effective by 95%.
Oxford and AstraZeneca published provisional results of efficacy on Monday, which showed that the vaccine can be 90% effective when given as a half dose followed by a full dose.
Britain’s chief science adviser said on Thursday that the provisional results showed the success of the Oxford / AstraZeneca vaccine.
– .
